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Abstract
Undifferentiated carcinoma of the ampulla of Vater is a rare disease with unclear and clinical characteristics and
prognosis. Here, we report the case of a 61-year-old man with undifferentiated carcinoma of the ampulla of Vater.
He presented to our hospital with an increase in hepatobiliary system enzymes that was detected during a health
check-up. Imaging and endoscopy demonstrated a tumor with ulcer in the ampulla of Vater, which was diagnosed as
a carcinoma by biopsy. No distant metastasis was observed. Subtotal stomach-preserving pancreaticoduodenectomy
was performed. Undifferentiated carcinoma was confirmed based on the presence of small round atypical cells with
the formation of a solid alveolar lesion on histopathological examination and immunohistochemical staining that was
positive for CAM 5.2 but negative for chromogranin A and synaptophysin. The tumor infiltrated the duodenum, but
not the pancreas; no lymph node metastasis was observed. However, liver metastases were detected 2 months
postoperatively. Chemotherapy was performed, and the tumor size temporality decreased; however, it grew in size
again, and the patients subsequently died of the primary disease 15 months postoperatively. Undifferentiated
carcinoma of the ampulla of Vater is a very rare histological type. More number of cases is necessary to
clarify optimal treatment.
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Background
Carcinoma of the ampulla of Vater most frequently pre-
sents with histopathological findings of cancer of inva-
sive adenocarcinoma accompanied by tubular growth
pattern, and undifferentiated carcinoma is rare. In fact,
undifferentiated carcinoma is reported to account for
3–7% of gallbladder cancer [1, 2], but only a few cases
of extrahepatic bile duct and papillary cancer [3, 4]
have been reported. We report the case of a patient
with undifferentiated carcinoma that developed in the
ampulla of Vater.
Case presentation
The patient was a 61-year-old male who presented to
our hospital with increased blood levels of hepatobili-
ary system enzymes detected during a health check-
up. He had a past medical history of hypertension
and appendectomy. He smoked ten cigarettes per day
for 40 years but had no history of habitual alcohol
drinking. There was no pertinent family medical his-
tory. His carcinoembryonic antigen level was 9.6 ng/
dL, and carbohydrate antigen 19–9 was lower than
the detection limit. On abdominal computed tomog-
raphy (CT), a 3-cm mass was present in the ampul-
lary region, and dilatation of the common and
intrahepatic bile ducts were noted (Fig. 1). On upper
gastrointestinal endoscopy, an ulcerative tumor with
raised margins was observed in the ampulla of Vater
(Fig. 2). On histopathological examination of the biopsy
specimen, irregular glandular duct structures and small
cells were present in a sheet pattern; these findings were
suggestive carcinoma, but the histological type could not
be identified.
Subtotal stomach-preserving pancreaticoduodenect-
omy was performed (Fig. 3). Histopathological exam-
ination of the resected specimen showed small
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round atypical cells that were mostly forming solid
nests without glandular duct structures (Fig. 4).
Ductal component was found in the small portion fa-
cing the lumen of the duodenum (Fig. 5). No
osteoclast-like giant cells or signet-ring cells were
noted. On immunohistochemical staining, CAM 5.2
was positive (Fig. 6a), both synaptophysin and chro-
mogranin A were negative (Fig. 6b, c), and CD56 was
weakly and focally positive (Fig. 6d). The tumor was
finally diagnosed as undifferentiated carcinoma of the
ampulla of Vater. The MIB-1 index was higher than
90% (Fig. 6e). The tumor infiltrated the duodenum,
but no infiltration in the pancreas was observed. Mild
lymphovascular and venous invasion were noted. No
perineural invasion or lymph node metastasis was
noted. Therefore, this tumor was classified as
T2N0M0 (Stage IB). No adjuvant chemotherapy was
performed.
Fig. 1 Abdominal CT. Axial (a) and coronal (b) images show a 3-cm tumor in the ampulla on Vater (white arrow) and dilatation of the common
bile duct
Fig. 2 Upper gastrointestinal endoscopy. An ulcerative tumor with raised margins in the ampulla of Vater
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Two months postoperatively, liver metastases were
discovered on abdominal CT (Fig. 7a). Combination
therapy with gemcitabine plus cisplatin was adminis-
tered, but the patient developed dyspnea, which was
attributed to heart failure secondary to mitral valve
prolapse as diagnosed using echocardiography. Con-
sidering that the load of cisplatin infusion could
aggravate the heart failure, combination chemother-
apy was switched to gemcitabine plus S-1. However,
the liver metastases were observed to be increased
on abdominal CT 6 months postoperatively (Fig. 7b).
Therefore, the treatment was switched back to
gemcitabine/cisplatin combination therapy with con-
comitant diuretics. Two months after restarting gem-
citabine plus cisplatin, there was resolution of liver
metastases as seen on abdominal CT (Fig. 7c).
However, 2 month later, abdominal CT revealed that
the liver metastases enlarged again despite the con-
tinuation of gemcitabine plus cisplatin (Fig. 7d).
Moreover, the symptoms of mitral valve prolapse-
associated heart failure worsened at this time and
continuation of chemotherapy became difficult. The
patient died of the primary disease 15 months
postoperatively.
Discussion
This was a rare case of undifferentiated carcinoma of the
ampulla of Vater. In this patient, the outcome was poor,
as demonstrated by the development of the liver metas-
tases at 2 months and subsequent death at 15 months
postoperatively.
Fig. 3 Gross findings of the resected specimen. The resected specimens demonstrated an ulcerative tumor with raised margins (a) and
involvement of the inferior bile duct (b)
Fig. 4 Pathological examination of the resected specimen. The tumor is highly cellular with minimal stroma and small cells with scant cytoplasm
arranged in solid nests (Hematoxylin and Eosin stain, ×200)
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According to the World Health Organization classi-
fication [5], there are two types of undifferentiated
carcinoma of the ampulla of Vater. One has a morph-
ology that is similar to that of neuroendocrine tumor
and is formed by relatively small cells with scant
cytoplasm, vesicular nuclei, and prominent nuclei ar-
ranged in solid sheets or nest. The other is composed
of spindle cells and is termed as sarcomatoid carcinoma.
Meanwhile, lesions with noticeable osteoclast-like multi-
nucleated giant cells are independently classified as undif-
ferentiated carcinoma with osteoclast-like giant cells. In
the present patient, majority of the small atypical cells
grew in the medullary portion of the tumor. Chromogra-
nin A, synaptophysin, and CD56 are well-known neuroen-
docrine markers. Among these, chromogranin A and
synaptophysin have been regarded as the most sensitive
markers for the diagnosis of neuroendocrine tumors [6].
On the other hand, the specificity of CD56 is questionable
[6] and its sensitivity is low [7, 8]. In the present case,
CD56 was only weakly and focally positive. Therefore, we
did not diagnose neuroendocrine tumor, including small
cell carcinoma. There was a ductal component in a small
portion of the tumor that faced the lumen of the
duodenum; we considered this portion as the site of
preoperative biopsy. Although undifferentiated carcin-
oma is characterized by the absence of glands, the
presence of small round atypical cells without ductal
differentiation in the majority of the tumor led us to
believe that the diagnosis in this case was undifferen-
tiated carcinoma. To the best of our knowledge, there
has been only one case report on undifferentiated
carcinoma of an ampullary lesion till date in which
small cells grew similar to those observed in the
present patient [4].
The prognosis of carcinoma of the ampulla of Vater is
relatively favorable among the biliary tract carcinoma
sites. The overall 5-year survival rate of ampullary
carcinoma patients was reported 61–68% [9, 10]. For
Stage IB ampullary cancer, which is the same stage as
that of our patient, the overall 5-year survival rate has
been reported to be 74.7% [9]. Moreover, the median
recurrence-free survival was 22.5 months; the incidence
of recurrence within 1 year was 21.8% in all patients and
13.8% in patients without lymph node metastasis [11].
Fig. 5 Transversely cut surface of the resected specimen. The small round atypical cells without ductal differentiation are present in the majority
of the tumor (parts surrounded by solid line). Ductal component is found in the small portion facing the lumen of the duodenum (part surrounded
by dotted line)
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Fig. 6 Immunohistochemical staining of the resected specimen. The tumor is positive for CAM 5.2 (a) but negative for synaptophysin (b) and
chromogranin A (c). CD56 is weakly positive (d). The labeling index of MIB-1 was >90% (e) (All photomicrographs, ×200)
Fig. 7 Serial abdominal computed tomography findings. Two months postoperatively, liver metastases are demonstrated (a), which increased
6 months postoperatively (b). The liver metastases resolved after 2 months of restarting gemcitabine plus cisplatin (c), but it enlarged again
2 months later (d)
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Lymph node metastasis and pancreatic invasion were
reported to be risk factors for recurrence [12]; these
were absent in our patients. However, liver metastases
developed 2 months postoperatively, and the outcome
was poor compared with other ampullary cancer
cases. MIB-1 is a cell growth marker. Although the
absence of a relationship between MIB-1 index and
prognosis has been reported in ampullary cancer, the
high tumor growth ability in the present case, as
demonstrated by the high MIB-1 index, may have in-
fluenced the poor outcome.
Aside from the ampulla of Vater, the gallbladder
and extrahepatic bile duct can also develop undiffer-
entiated biliary tract carcinoma; compared with other
histological types, undifferentiated carcinoma of the
gallbladder has been reported to have a poor progno-
sis [2]. On the other hand, undifferentiated carcinoma
of the common bile duct grew in a polypoid pattern
and could be discovered in an early stage, leading to
favorable prognosis [3].
The standard chemotherapy regimen for recurrent
biliary tract carcinoma is gemcitabine plus cisplatin
[13], but gemcitabine plus S-1 is also effective [14].
In our patient, gemcitabine plus S-1 regimen was in-
effective, but the gemcitabine plus cisplatin regimen
temporarily reduced the size of liver metastases.
Gemcitabine was reported to achieve complete remis-
sion of undifferentiated carcinoma with osteoclast-
like giant cells in the periampullary region [15]. But
the effect of chemotherapy on undifferentiated car-
cinoma of the biliary tract system is unclear because
of the small number of cases. The transient effect
observed in the present patient is a matter to be
noted and should be taken into account in the
future.
Conclusions
Undifferentiated carcinoma of the ampulla of Vater is a
very rare histological type. The present case showed a
poor outcome, with development of liver metastases at
2 months and death at 15 months postoperatively. There
are very few case reports on undifferentiated carcinoma
of the ampulla of Vater, and many points on prognosis
and treatment methods remain unclear. More number
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